<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:DOC-VP0D3Z3L</identifier><date>2013</date><creator>Trošt, Nina</creator><relation>documents/doc/V/URN_NBN_SI_doc-VP0D3Z3L_001.pdf</relation><relation>documents/doc/V/URN_NBN_SI_doc-VP0D3Z3L_001.txt</relation><relation>https://repozitorij.uni-lj.si/IzpisGradiva.php?id=76659</relation><format format_type="type">doktorska dela</format><identifier identifier_type="COBISSID_HOST">7627385</identifier><identifier identifier_type="PID">https://repozitorij.uni-lj.si/IzpisGradiva.php?id=76659</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-VP0D3Z3L</identifier><language>slv</language><publisher>Ljubljana: N. Trošt</publisher><source>visokošolska dela</source><rights>InC</rights><subject language_type_id="slv">apoptoza</subject><subject language_type_id="slv">celična proliferacija</subject><subject language_type_id="slv">celične linije</subject><subject language_type_id="eng">cisplatin</subject><subject language_type_id="slv">citotoksičnost</subject><subject language_type_id="slv">Disertacije</subject><subject language_type_id="slv">Dojka</subject><subject language_type_id="eng">eritropoetin</subject><subject language_type_id="slv">estrogenski receptorji</subject><subject language_type_id="slv">gensko izražanje</subject><subject language_type_id="slv">hormonsko odvisni rak</subject><subject language_type_id="eng">molecular biology</subject><subject language_type_id="slv">Molekularna biologija</subject><subject language_type_id="slv">Rak (medicina)</subject><subject language_type_id="slv">rekombinantni humani eritropoetin</subject><subject language_type_id="slv">signalne poti</subject><subject language_type_id="slv">tamoksifen</subject><subject language_type_id="slv">viabilnost</subject><title>doktorska disertacija</title><title>The effect of recombinant human erythropoietin on the growth and survivale of breast cancer cells and their responsivenes to cisplatin and tamoxifen</title><title>Vpliv rekombinantnega humanega eritropoetina na rast in preživetje celic raka dojke ter njihovo odzivnost na cisplatin in tamoksifen</title></Record>